Industry: Medical Devices & Consumables
Published Date: 2025-11-02
Pages: 95 Pages
Report ld: 5353180
Request Sample
Customized Report
The global Enoxaparin Sodium Prefilled Syringes market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
By 2025, the evolving U.S. tariff policy is poised to inject considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the globe, evaluating their impacts on Enoxaparin Sodium Prefilled Syringes market competitiveness, regional economic performance, and supply chain configurations.
Enoxaparin sodium is an anticoagulant medication (blood thinner).It is used to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE) including during pregnancy and following certain types of surgery. It is also used in those with acute coronary syndrome (ACS) and heart attacks. It is given by injection just under the skin or into a vein. Prefilled syringes and graduated prefilled syringes are preservative-free and intended for use only as a single-dose injection.
With the continuous advancement of medical technology, prefilled syringes have been playing an increasingly vital role in the field of pharmaceutical delivery. Enoxaparin sodium, a commonly used anticoagulant medication, is now being offered in the form of prefilled syringes known as Enoxaparin Sodium Prefilled Syringes. This innovative delivery method is gradually becoming the preferred choice for anticoagulant therapy, driven by its convenience and precise dosing capabilities. The Enoxaparin Sodium Prefilled Syringes not only reduce the complexity for healthcare providers but also offer patients a more comfortable and convenient medication experience. As the aging population grows and anticoagulant treatments continue to see widespread adoption, the market for Enoxaparin Sodium Prefilled Syringes is poised for sustained growth.
The global Enoxaparin Sodium Prefilled Syringes market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Enoxaparin Sodium Prefilled Syringes market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., 30 mg/0.3mL in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Clinic in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Enoxaparin Sodium Prefilled Syringes value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Enoxaparin Sodium Prefilled Syringes Product Scope
1.2 Enoxaparin Sodium Prefilled Syringes by Type
1.2.1 Global Enoxaparin Sodium Prefilled Syringes Sales by Type (2020 & 2024 & 2031)
1.2.2 20 mg/0.2mL
1.2.3 30 mg/0.3mL
1.2.4 40 mg/0.4mL
1.2.5 60 mg/0.6mL
1.2.6 80 mg/0.8mL
1.2.7 100 mg/1mL
1.2.8 120 mg/0.8mL
1.2.9 150 mg/1mL
1.3 Enoxaparin Sodium Prefilled Syringes by Application
1.3.1 Global Enoxaparin Sodium Prefilled Syringes Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Enoxaparin Sodium Prefilled Syringes Market Estimates and Forecasts (2020-2031)
1.4.1 Global Enoxaparin Sodium Prefilled Syringes Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Enoxaparin Sodium Prefilled Syringes Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Enoxaparin Sodium Prefilled Syringes Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Enoxaparin Sodium Prefilled Syringes Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Enoxaparin Sodium Prefilled Syringes Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Enoxaparin Sodium Prefilled Syringes Sales Market Share by Region (2020-2025)
2.2.2 Global Enoxaparin Sodium Prefilled Syringes Revenue Market Share by Region (2020-2025)
2.3 Global Enoxaparin Sodium Prefilled Syringes Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Enoxaparin Sodium Prefilled Syringes Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Enoxaparin Sodium Prefilled Syringes Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Enoxaparin Sodium Prefilled Syringes Market Size and Prospective (2020-2031)
2.4.2 Europe Enoxaparin Sodium Prefilled Syringes Market Size and Prospective (2020-2031)
2.4.3 China Enoxaparin Sodium Prefilled Syringes Market Size and Prospective (2020-2031)
2.4.4 Japan Enoxaparin Sodium Prefilled Syringes Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Enoxaparin Sodium Prefilled Syringes Historic Market Review by Type (2020-2025)
3.1.1 Global Enoxaparin Sodium Prefilled Syringes Sales by Type (2020-2025)
3.1.2 Global Enoxaparin Sodium Prefilled Syringes Revenue by Type (2020-2025)
3.1.3 Global Enoxaparin Sodium Prefilled Syringes Price by Type (2020-2025)
3.2 Global Enoxaparin Sodium Prefilled Syringes Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Enoxaparin Sodium Prefilled Syringes Sales Forecast by Type (2026-2031)
3.2.2 Global Enoxaparin Sodium Prefilled Syringes Revenue Forecast by Type (2026-2031)
3.2.3 Global Enoxaparin Sodium Prefilled Syringes Price Forecast by Type (2026-2031)
3.3 Different Types Enoxaparin Sodium Prefilled Syringes Representative Players
4 Global Market Size by Application
4.1 Global Enoxaparin Sodium Prefilled Syringes Historic Market Review by Application (2020-2025)
4.1.1 Global Enoxaparin Sodium Prefilled Syringes Sales by Application (2020-2025)
4.1.2 Global Enoxaparin Sodium Prefilled Syringes Revenue by Application (2020-2025)
4.1.3 Global Enoxaparin Sodium Prefilled Syringes Price by Application (2020-2025)
4.2 Global Enoxaparin Sodium Prefilled Syringes Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Enoxaparin Sodium Prefilled Syringes Sales Forecast by Application (2026-2031)
4.2.2 Global Enoxaparin Sodium Prefilled Syringes Revenue Forecast by Application (2026-2031)
4.2.3 Global Enoxaparin Sodium Prefilled Syringes Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Enoxaparin Sodium Prefilled Syringes Application
5 Competition Landscape by Players
5.1 Global Enoxaparin Sodium Prefilled Syringes Sales by Players (2020-2025)
5.2 Global Top Enoxaparin Sodium Prefilled Syringes Players by Revenue (2020-2025)
5.3 Global Enoxaparin Sodium Prefilled Syringes Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enoxaparin Sodium Prefilled Syringes as of 2024)
5.4 Global Enoxaparin Sodium Prefilled Syringes Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Enoxaparin Sodium Prefilled Syringes, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Enoxaparin Sodium Prefilled Syringes, Product Type & Application
5.7 Global Key Manufacturers of Enoxaparin Sodium Prefilled Syringes, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Enoxaparin Sodium Prefilled Syringes Sales by Company
6.1.1.1 North America Enoxaparin Sodium Prefilled Syringes Sales by Company (2020-2025)
6.1.1.2 North America Enoxaparin Sodium Prefilled Syringes Revenue by Company (2020-2025)
6.1.2 North America Enoxaparin Sodium Prefilled Syringes Sales Breakdown by Type (2020-2025)
6.1.3 North America Enoxaparin Sodium Prefilled Syringes Sales Breakdown by Application (2020-2025)
6.1.4 North America Enoxaparin Sodium Prefilled Syringes Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Enoxaparin Sodium Prefilled Syringes Sales by Company
6.2.1.1 Europe Enoxaparin Sodium Prefilled Syringes Sales by Company (2020-2025)
6.2.1.2 Europe Enoxaparin Sodium Prefilled Syringes Revenue by Company (2020-2025)
6.2.2 Europe Enoxaparin Sodium Prefilled Syringes Sales Breakdown by Type (2020-2025)
6.2.3 Europe Enoxaparin Sodium Prefilled Syringes Sales Breakdown by Application (2020-2025)
6.2.4 Europe Enoxaparin Sodium Prefilled Syringes Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Enoxaparin Sodium Prefilled Syringes Sales by Company
6.3.1.1 China Enoxaparin Sodium Prefilled Syringes Sales by Company (2020-2025)
6.3.1.2 China Enoxaparin Sodium Prefilled Syringes Revenue by Company (2020-2025)
6.3.2 China Enoxaparin Sodium Prefilled Syringes Sales Breakdown by Type (2020-2025)
6.3.3 China Enoxaparin Sodium Prefilled Syringes Sales Breakdown by Application (2020-2025)
6.3.4 China Enoxaparin Sodium Prefilled Syringes Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Enoxaparin Sodium Prefilled Syringes Sales by Company
6.4.1.1 Japan Enoxaparin Sodium Prefilled Syringes Sales by Company (2020-2025)
6.4.1.2 Japan Enoxaparin Sodium Prefilled Syringes Revenue by Company (2020-2025)
6.4.2 Japan Enoxaparin Sodium Prefilled Syringes Sales Breakdown by Type (2020-2025)
6.4.3 Japan Enoxaparin Sodium Prefilled Syringes Sales Breakdown by Application (2020-2025)
6.4.4 Japan Enoxaparin Sodium Prefilled Syringes Major Customer
6.4.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Sanofi
7.1.1 Sanofi Company Information
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Enoxaparin Sodium Prefilled Syringes Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Sanofi Enoxaparin Sodium Prefilled Syringes Products Offered
7.1.5 Sanofi Recent Development
7.2 Teva
7.2.1 Teva Company Information
7.2.2 Teva Business Overview
7.2.3 Teva Enoxaparin Sodium Prefilled Syringes Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Teva Enoxaparin Sodium Prefilled Syringes Products Offered
7.2.5 Teva Recent Development
7.3 Rovi
7.3.1 Rovi Company Information
7.3.2 Rovi Business Overview
7.3.3 Rovi Enoxaparin Sodium Prefilled Syringes Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Rovi Enoxaparin Sodium Prefilled Syringes Products Offered
7.3.5 Rovi Recent Development
7.4 Amphastar
7.4.1 Amphastar Company Information
7.4.2 Amphastar Business Overview
7.4.3 Amphastar Enoxaparin Sodium Prefilled Syringes Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Amphastar Enoxaparin Sodium Prefilled Syringes Products Offered
7.4.5 Amphastar Recent Development
7.5 Techdow (Hepalink)
7.5.1 Techdow (Hepalink) Company Information
7.5.2 Techdow (Hepalink) Business Overview
7.5.3 Techdow (Hepalink) Enoxaparin Sodium Prefilled Syringes Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Techdow (Hepalink) Enoxaparin Sodium Prefilled Syringes Products Offered
7.5.5 Techdow (Hepalink) Recent Development
7.6 Fresenius Kabi
7.6.1 Fresenius Kabi Company Information
7.6.2 Fresenius Kabi Business Overview
7.6.3 Fresenius Kabi Enoxaparin Sodium Prefilled Syringes Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Fresenius Kabi Enoxaparin Sodium Prefilled Syringes Products Offered
7.6.5 Fresenius Kabi Recent Development
7.7 Nanjing King-friend
7.7.1 Nanjing King-friend Company Information
7.7.2 Nanjing King-friend Business Overview
7.7.3 Nanjing King-friend Enoxaparin Sodium Prefilled Syringes Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Nanjing King-friend Enoxaparin Sodium Prefilled Syringes Products Offered
7.7.5 Nanjing King-friend Recent Development
7.8 Sandoz
7.8.1 Sandoz Company Information
7.8.2 Sandoz Business Overview
7.8.3 Sandoz Enoxaparin Sodium Prefilled Syringes Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Sandoz Enoxaparin Sodium Prefilled Syringes Products Offered
7.8.5 Sandoz Recent Development
7.9 Apotex
7.9.1 Apotex Company Information
7.9.2 Apotex Business Overview
7.9.3 Apotex Enoxaparin Sodium Prefilled Syringes Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Apotex Enoxaparin Sodium Prefilled Syringes Products Offered
7.9.5 Apotex Recent Development
7.10 Hangzhou Jiuyuan Gene Engineering
7.10.1 Hangzhou Jiuyuan Gene Engineering Company Information
7.10.2 Hangzhou Jiuyuan Gene Engineering Business Overview
7.10.3 Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Prefilled Syringes Sales, Revenue and Gross Margin (2020-2025)
7.10.4 Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Prefilled Syringes Products Offered
7.10.5 Hangzhou Jiuyuan Gene Engineering Recent Development
7.11 Cipla
7.11.1 Cipla Company Information
7.11.2 Cipla Business Overview
7.11.3 Cipla Enoxaparin Sodium Prefilled Syringes Sales, Revenue and Gross Margin (2020-2025)
7.11.4 Cipla Enoxaparin Sodium Prefilled Syringes Products Offered
7.11.5 Cipla Recent Development
7.12 Taj Pharma
7.12.1 Taj Pharma Company Information
7.12.2 Taj Pharma Business Overview
7.12.3 Taj Pharma Enoxaparin Sodium Prefilled Syringes Sales, Revenue and Gross Margin (2020-2025)
7.12.4 Taj Pharma Enoxaparin Sodium Prefilled Syringes Products Offered
7.12.5 Taj Pharma Recent Development
7.13 Chengdu Baiyu Pharmaceutical
7.13.1 Chengdu Baiyu Pharmaceutical Company Information
7.13.2 Chengdu Baiyu Pharmaceutical Business Overview
7.13.3 Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Prefilled Syringes Sales, Revenue and Gross Margin (2020-2025)
7.13.4 Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Prefilled Syringes Products Offered
7.13.5 Chengdu Baiyu Pharmaceutical Recent Development
7.14 Changzhou Qianhong Bio-pharma
7.14.1 Changzhou Qianhong Bio-pharma Company Information
7.14.2 Changzhou Qianhong Bio-pharma Business Overview
7.14.3 Changzhou Qianhong Bio-pharma Enoxaparin Sodium Prefilled Syringes Sales, Revenue and Gross Margin (2020-2025)
7.14.4 Changzhou Qianhong Bio-pharma Enoxaparin Sodium Prefilled Syringes Products Offered
7.14.5 Changzhou Qianhong Bio-pharma Recent Development
8 Enoxaparin Sodium Prefilled Syringes Manufacturing Cost Analysis
8.1 Enoxaparin Sodium Prefilled Syringes Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Enoxaparin Sodium Prefilled Syringes
8.4 Enoxaparin Sodium Prefilled Syringes Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Enoxaparin Sodium Prefilled Syringes Distributors List
9.3 Enoxaparin Sodium Prefilled Syringes Customers
10 Enoxaparin Sodium Prefilled Syringes Market Dynamics
10.1 Enoxaparin Sodium Prefilled Syringes Industry Trends
10.2 Enoxaparin Sodium Prefilled Syringes Market Drivers
10.3 Enoxaparin Sodium Prefilled Syringes Market Challenges
10.4 Enoxaparin Sodium Prefilled Syringes Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Enoxaparin Sodium Prefilled Syringes was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 144
USD 3950.00
(Single User License)
The global Enoxaparin Sodium Prefilled Syringes market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-17
Pages: 118
USD 2900.00
(Single User License)
The global Enoxaparin Sodium Prefilled Syringes market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 166
USD 4900.00
(Single User License)
The global market for Enoxaparin Sodium Prefilled Syringes was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 112
USD 3950.00
(Single User License)
The global market for Enoxaparin Sodium Prefilled Syringes was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-13
Pages: 88
USD 2900.00
(Single User License)
Enoxaparin sodium is an anticoagulant medication (blood thinner).It is used to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE) including during pregnancy and following certain types of surgery. It is also used in those with acute coronary syndrome (ACS) and heart attacks. It is given by injection just under the skin or into a vein. Prefilled syringes and graduated prefilled syringes are preservative-free and intended for use only as a single-dose injection.
Published Date: 2024-01-17
Pages: 91
USD 2900.00
(Single User License)
The global market for Enoxaparin Sodium Prefilled Syringes was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 144
The global Enoxaparin Sodium Prefilled Syringes market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-17
Pages: 118
The global Enoxaparin Sodium Prefilled Syringes market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 166
The global market for Enoxaparin Sodium Prefilled Syringes was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 112
The global market for Enoxaparin Sodium Prefilled Syringes was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-13
Pages: 88
Enoxaparin sodium is an anticoagulant medication (blood thinner).It is used to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE) including during pregnancy and following certain types of surgery. It is also used in those with acute coronary syndrome (ACS) and heart attacks. It is given by injection just under the skin or into a vein. Prefilled syringes and graduated prefilled syringes are preservative-free and intended for use only as a single-dose injection.
Published: 2024-01-17
Pages: 91
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now